Holding(s) in Company

CRH PLC
28 September 2023
 

Standard Form TR-1
Voting rights attached to shares- Article 12(1) of directive 2004/109/EC
Financial instruments - Article 11(3) of the Commission Directive 2007/14/EC
[i]

1.         Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached [ii]:

CRH PLC

2.         Reason for the notification (please tick the appropriate box or boxes):

[ ]      an acquisition or disposal of voting rights

[ ]      an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

[ ]      an event changing the breakdown of voting rights

[X]    other: Entry filing due to delisting from EURONEXT Dublin and as part of Part 17 requirements.

3.         Full name of person(s) subject to the notification obligation[iii]:

BlackRock, Inc.

4.         Full name of shareholder(s) (if different from 3.)[iv]:

See Section 9

5.         Date of the transaction and date on which the threshold is crossed or reached[v]: 25/09/2023

6.         Date on which issuer notified: 27/09/2023

7.         Threshold(s) that is/are crossed or reached:

Total holdings for BlackRock, Inc. have gone above 4%. Additionally, voting rights attached to shares for BlackRock, Inc. have gone above 4%.

8.         Notified details:      

A) Voting rights attached to shares

Class/type of shares (if possible using the ISIN CODE)

Situation previous to the Triggering transaction [vi]

Resulting situation after the triggering transaction[vii][viii]

Number of Shares[ix]

Number of Voting rights[x]

Number of shares[xi]

Number of voting rights[xii]

% of voting rights

Direct

Direct[xiii]

Indirect[xiv]

Direct

Indirect

IE0001827041

N/A

N/A

N/A

N/A

34,115,331

N/A

4.77%

SUBTOTAL A (based on aggregate voting rights)




34,115,331

4.77%

 

B) Financial Instruments

Resulting situation after the triggering transaction[xv]

Type of financial instrument

Expiration Date[xvi]

Exercise/Conversion  Period/ Date[xvii]

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

CFD

N/A

N/A

509,428

 

0.07%

Securities Lending

N/A

N/A

123,589

 

0.01%


SUBTOTAL B (in relation to all expiration dates)

633,017

0.08%

 

Total (A+B)

number of voting rights

% of voting rights

34,748,348

34,748,348

4.85%

 

9.         Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable[xviii]:

 

Each of the following entities, which are wholly owned subsidiaries of BlackRock, Inc., hold the following interests in voting rights in their capacity as Investment Manager on behalf of clients:

Investment Manager

Voting Rights

%

BlackRock Fund Advisors

12,029,627

1.68%

BlackRock Institutional Trust Company, National Association

9,173,503

1.28%

BlackRock Advisors (UK) Limited

5,837,663

0.81%

BlackRock Investment Management (UK) Limited

2,699,802

0.37%

BlackRock Japan Co., Ltd.

1,262,829

0.17%

BlackRock Investment Management, LLC

1,115,091

0.15%

BlackRock Asset Management Canada Limited

774,834

0.10%

BlackRock Asset Management Deutschland AG

731,255

0.10%

BlackRock Advisors, LLC

604,750

0.08%

BlackRock Financial Management, Inc.

236,149

0.03%

BlackRock Investment Management (Australia) Limited

200,956

0.02%

BlackRock Asset Management North Asia Limited

47,341

0.00%

Aperio Group, LLC

13,119

0.00%

BlackRock International Limited

10,984

0.00%

BlackRock Capital Management, Inc.

7,809

0.00%

BlackRock (Singapore) Limited

2,636

0.00%

 

 

10.       In case of proxy voting: [name of the proxy holder] will cease to hold [number] voting rights as of [date].

11.       Additional information:

Done at 12 Throgmorton Avenue, London, EC2N 2DL, U.K. on 27 September 2023

 

 



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

CRH (CDI) (CRH)
UK 100

Latest directors dealings